Blood and Marrow Transplant Clinical Research Network
This study has been completed.
Sponsor:
Collaborator:
Blood and Marrow Transplant Clinical Trials Network
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00023530
First received: September 7, 2001
Last updated: November 29, 2007
Last verified: July 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
| Condition | Intervention |
|---|---|
|
Bone Marrow Transplantation Blood Disease Hematopoietic Stem Cell Transplantation Leukemia Multiple Myeloma Myelodysplastic Syndromes Graft vs Host Disease |
Drug: fluconazole Drug: voriconazole Procedure: bone marrow transplant Drug: thalidomide Drug: dexamethasone |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Masking: Double-Blind Primary Purpose: Prevention |
| Official Title: | Blood and Marrow Transplant Clinical Research Network |
Resource links provided by NLM:
MedlinePlus related topics:
Blood Disorders
Bone Marrow Transplantation
Cancer
Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
Drug Information available for:
Dexamethasone
Thalidomide
Dexamethasone acetate
Dexamethasone sodium phosphate
Fluconazole
Voriconazole
U.S. FDA Resources
Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):
Eligibility| Ages Eligible for Study: | 2 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Criteria for entry into a study varies by protocol
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00023530
Locations
| United States, California | |
| City of Hope National Medical Center | |
| Duarte, California, United States, 91010 | |
| University of California at San Diego | |
| La Jolla, California, United States, 92093 | |
| Stanford University | |
| Palo Alto, California, United States, 94305 | |
| United States, Florida | |
| University of Florida | |
| Gainesville, Florida, United States, 32610 | |
| United States, Maryland | |
| Johns Hopkins University | |
| Baltimore, Maryland, United States, 21231 | |
| United States, Massachusetts | |
| Dana-Farber Cancer Institute | |
| Boston, Massachusetts, United States, 02115 | |
| United States, Michigan | |
| University of Michigan at Ann Arbor | |
| Ann Arbor, Michigan, United States, 48109 | |
| United States, Minnesota | |
| University of Minnesota Twin Cities | |
| Minneapolis, Minnesota, United States, 55455 | |
| United States, Missouri | |
| Children's Mercy Hospital | |
| Kansas City, Missouri, United States, 64108 | |
| United States, Nebraska | |
| University of Nebraska Medical Center | |
| Omaha, Nebraska, United States, 68198 | |
| United States, New York | |
| Sloan-Kettering Institute for Cancer Research | |
| New York, New York, United States, 10021 | |
| United States, North Carolina | |
| Duke University | |
| Durham, North Carolina, United States, 27705 | |
| United States, Ohio | |
| Case Western Reserve University | |
| Cleveland, Ohio, United States, 44106 | |
| United States, Pennsylvania | |
| University of Pennsylvania | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| United States, Texas | |
| MD Anderson Cancer Center | |
| Houston, Texas, United States, 77030 | |
| United States, Washington | |
| Fred Hutchinson Cancer Research Center | |
| Seattle, Washington, United States, 98109 | |
Sponsors and Collaborators
Blood and Marrow Transplant Clinical Trials Network
Investigators
| Investigator: | Joseph Antin | Dana-Farber Cancer Institute |
| Investigator: | Frederick Appelbaum | Fred Hutchinson Cancer Research Center |
| Investigator: | Edward Ball | University of California, San Diego |
| Investigator: | James Ferrara | University of Michigan at Ann Arbor |
| Investigator: | Stephen Forman | City of Hope National Medical Center |
| Investigator: | Alan Gamis | Children's Mercy Hospital |
| Investigator: | Sergio Giralt | M.D. Anderson Cancer Center |
| Investigator: | Mary Horowitz | Medical College of Wisconsin |
| Investigator: | Richard Jones | Johns Hopkins University |
| Investigator: | Joanne Kurtzberg | Duke University |
| Investigator: | Gina Laport | Stanford University |
| Investigator: | Hillard Lazarus | Case Western Reserve University |
| Investigator: | Richard O'Reilly | Sloan-Kettering Institute for Cancer Research |
| Investigator: | Edward Stadtmauer | University of Pennsylvania |
| Investigator: | Julie Vose | University of Nebraska |
| Investigator: | Daniel Weisdorf | University of Minnesota - Clinical and Translational Science Institute |
| Investigator: | John Wingard | University of Florida |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00023530 History of Changes |
| Other Study ID Numbers: | 139 |
| Study First Received: | September 7, 2001 |
| Last Updated: | November 29, 2007 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Graft vs Host Disease Hematologic Diseases Leukemia Multiple Myeloma Neoplasms, Plasma Cell Myelodysplastic Syndromes Preleukemia Immune System Diseases Neoplasms by Histologic Type Neoplasms Hemostatic Disorders Vascular Diseases Cardiovascular Diseases Paraproteinemias Blood Protein Disorders |
Hemorrhagic Disorders Lymphoproliferative Disorders Immunoproliferative Disorders Bone Marrow Diseases Precancerous Conditions Dexamethasone acetate Dexamethasone Dexamethasone 21-phosphate Thalidomide BB 1101 Fluconazole Voriconazole Anti-Inflammatory Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 22, 2013